Drug reference

fam-trastuzumab deruxtecan-nxki

Mosby’s 2024 Nursing Drug Reference

Source: Mosby’s 2024 Nursing Drug Reference
PDF pages: 547

Review source pages for extracted sections and age labels.

Overview

Names and pronunciation

Enhertu

PDF page 547

Functional class

Func. class.: Antineoplastic, HER2- directed antibody

PDF page 547

Uses

USES: HER2-positive metastatic breast cancer

PDF page 547

Safety

Contraindications

CONTRAINDICATIONS Hypersensitivity

PDF page 547

Dose and formulations

Dosage and routes

DOSAGE AND ROUTES Adult: Intermittent IV Infusion 5.4 mg/kg once q3wk (21-day cycle) until disease progression or unacceptable toxicity

PDF page 547

Available forms

Available forms: Solution reconstituted IV 100 mg

PDF page 547

Age labels are extracted for navigation. Check the complete source section and current local guidance before clinical use.

Drug reference

fam-trastuzumab deruxtecan-nxki

Mosby’s 2024 Nursing Drug Reference

Source: Mosby’s 2024 Nursing Drug Reference
PDF pages: 547

Review source pages for extracted sections and age labels.

Overview

Names and pronunciation

Enhertu

PDF page 547

Functional class

Func. class.: Antineoplastic, HER2- directed antibody

PDF page 547

Uses

USES: HER2-positive metastatic breast cancer

PDF page 547

Safety

Contraindications

CONTRAINDICATIONS Hypersensitivity

PDF page 547

Dose and formulations

Dosage and routes

DOSAGE AND ROUTES Adult: Intermittent IV Infusion 5.4 mg/kg once q3wk (21-day cycle) until disease progression or unacceptable toxicity

PDF page 547

Available forms

Available forms: Solution reconstituted IV 100 mg

PDF page 547

Age labels are extracted for navigation. Check the complete source section and current local guidance before clinical use.